F31External beam radiation therapy (EBRT) use and safety with radium-223 dichloride (Ra-223) in patients (pts) with castration-resistant prostate cancer (CRPC) and symptomatic bone metastases (mets) from the ALSYMPCA trial:
Paganelli, G., Rossetti, C., Aglietta, M., Messina, C., Versari, A., Michalski, J.M., O'Sullivan, J.M., Parker, C., Garcia-Vargas, J.E., Sartor, A., Finkelstein, S.E.Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv341.31
Date:
October, 2015
File:
PDF, 42 KB
english, 2015
File converter
More search results
More benefits 
